Literature DB >> 5832853

Cure of mice bearing advanced plasma cell tumours with aniline mustard.

M E Whisson, T A Connors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5832853     DOI： 10.1038/206689a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

Review 2.  [Metabolic pathways of cyclophosphamide].

Authors:  K Norpoth; H M Rauen
Journal:  Klin Wochenschr       Date:  1972-05-01

3.  Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.

Authors:  N Brock
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 4.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  The biology of large solid tumours regressing with nitrogen mustard treatment: a study of the mouse plasma cell tumour Adj-pc-5 and the Walker carcinosarcoma 256.

Authors:  R J Goldacre; M E Whisson
Journal:  Br J Cancer       Date:  1966-12       Impact factor: 7.640

6.  Response of a high-glucuronidase human tumour xenograft to aniline mustard.

Authors:  H M Warenius; P Workman; N M Bleehen
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

7.  Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.

Authors:  D R Newell; K M Searle; N B Westwood; S S Burtles
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.